Regulatory Approvals
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Track global regulatory approvals for new drugs and biologics. Stay ahead in pharma BD with critical FDA, EMA, and PMDA insights.
Showing 1–5 of 5 articles
Quick answer
NovaPharmaNews Regulatory Approvals hub for NMPA covers 5 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Arrowhead Pharmaceuticals Receives TGA Approval for REDEMPLO (Plozasiran) in Australia for Rare Genetic Disorder
FDA Approves Auvelity: A New Option for MDD
FDA Approves Auvelity for MDD: A New Antidepressant Option
BioMarin Completes $3 Billion Acquisition of Amicus Therapeutics, Expands Rare Disease Portfolio with Galafold and Pompe Therapies
Sonorous Neurovascular Receives FDA 510(k) Clearance for BosCATH™ Neurovascular Catheter
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.